Check out the paper on "Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART." in Nature Communications by EVBC member Niko Beerenwinkel and colleagues nature.com/articles/s4146…

My first phd paper finally out! Lots of recombination in HIV genomes from Uganda. academic.oup.com/ve/article/6/1…

JT McCrone gave an awesome talk today describing analysis on the global spread of #SARSCoV2. A gentle intro to phylogenetics at the start too, so worth a watch for any wanting to know more about how we use genetic info to track viral spread! Watch here: media.ed.ac.uk/media/1_3kixf0…

me overhearing gossip in the lab

2 #PhDs in our group The ICR Centre for Evolution and Cancer, ICR Are you a #maths #modeller interested in cancer genomics and metastasis evolution? icr.ac.uk/media/docs/def… Or are you a #immunologist keen to develop new tech to map T-cells in situ in cancer? (with Benny Chain) icr.ac.uk/media/docs/def…

I am excited to advertise an opportunity for a scientific officer position to work with me and Trevor Graham to experimentally test predictions about therapy resistance evolution in our group at the The ICR, Centre for Evolution and Cancer, ICR Application here: jobs.icr.ac.uk/vacancies/419/…

Phylogenetic analysis of the cheilostome bryozoa confirms parental care evolves again and again. So proud and grateful to have worked on this project! #EvolutionaryBiology #ScienceDiscoveries #Bryozoans

Inflammatory bowel disease (#IBD) increases bowel cancer risk: 1/3 of patients with low grade dysplasia (LGD) will get cancer. This risk is very high &reason for treatment. But also major conundrum b/c 2/3 patients with LGD won't get cancer. Can we know who is really at risk? 1/3

1. Delighted to present work from my time in Andrea Sottoriva's lab, now in Nature Cancer! A big effort also led by Javier Fernández-Mateos and Nick Trahearn. We combined genomics + digital pathology to measure evolution in a prostate cancer (PCa) clinical trial. nature.com/articles/s4301…